Industry is fighting FDA’s proposed order to require PMAs for automated external defibrillators, saying the devices’ safety and effectiveness have been demonstrated and the 501(k) route with class II special controls is appropriate.
FDA’s March proposal, if finalized, would require AED manufacturers to submit PMAs for the devices. Since the devices were on...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?